In human colon cancer (CRC), inhibition of SUV39H1 significantly increases the expression of granulozyme B, perforin, FasL, and IFN, inducing tumor cell apoptosis by enhancing immune surveillance and the killing effect of CTL (Lu et al., 2019). The gene discussed is FASLG; the disease is colorectal carcinoma.